|
| |
| | | 44611 | | 22.08.1986 | | Novo Nordisk Pharma AG | | | | | | | | | | | | | | | 31.03.2008 | | | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 02 | Insulin NovoNordisk Monotard HM 100 IE/mL | Injektionssuspension | Injection suspension (Insulin Human 30 %, Insulin Human Zinc Crystalline 70 %) | A10AC01 | CI |
|
|
|
